- 11/12/2015IR
Supplement Documents for Financial Results Q3 FY 12/15
Supplement Documents for Financial Results Q3 FY 12/15
- 11/12/2015IR
Non-Consolidated Financial Results (Japanese GAAP) for the Nine Months Ended September 30, 2015
Non-Consolidated Financial Results (Japanese GAAP) for the Nine Months Ended September 30, 2015
- 08/14/2015IR
Supplement Documents for Financial Results Q2 FY12/15
Supplement Documents for Financial Results Q2 FY12/15
- 08/14/2015IR
Consolidated Financial Results (Japanese GAAP) for the Six Months Ended June 30, 2015
Consolidated Financial Results (Japanese GAAP) for the Six Months Ended June 30, 2015
- 05/26/2015IR
Execution of an Option License Agreement for LIV-1205, an anti-cancer antibody developed by Chiome’s affiliate
Execution of an Option License Agreement for LIV-1205, an anti-cancer antibody developed by Chiome’s affiliate
- 05/14/2015IR
Supplement Documents for Financial Results Q1 FY12/15
Supplement Documents for Financial Results Q1 FY12/15
- 05/14/2015IR
Consolidated Financial Results (Japanese GAAP) for the Three Months Ended March 31, 2015
Consolidated Financial Results (Japanese GAAP) for the Three Months Ended March 31, 2015
- 02/13/2015IR
Supplement Documents for Financial Results FY12/14
Supplement Documents for Financial Results FY12/14
- 02/13/2015IR
Consolidated Financial Results (Japanese GAAP) for the Fiscal Period Ended December 31, 2014
Consolidated Financial Results (Japanese GAAP) for the Fiscal Period Ended December 31, 2014
- 01/07/2015IR
Patent for ADLib axCELL granted in Japan
Patent for ADLib axCELL granted in Japan
- Top
- News